Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/56987| Title: | Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report |
| Keywords: | Leishmania Glucantime Neglected disease Doenças negligenciadas |
| Issue Date: | 2023 |
| Citation: | SOUZA, M. V. de et al. Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report. Brazilian Journal of Health Review, Curitiba, v. 6, n.1, p. 3323-3328, Jan./Feb. 2023. |
| Abstract: | Cutaneous leishmaniasis (CL) is not a life-threatening condition, the treatment of which can cause serious adverse effects and sometimes lead to death. In this study, we report a case of success in the treatment of LC of a 2.5 cm lesion located in the neck region of a 22-year-old man treated with intralesional meglumine antiomoniate (IL-MA) without adverse effects and without recurrence or complications after 18 months of follow-up. The results suggest that the treatment of CL lesions with IL-MA is simple, efficient and safe. |
| URI: | https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214 http://repositorio.ufla.br/jspui/handle/1/56987 |
| Appears in Collections: | DMV - Artigos publicados em periódicos |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.